Highest-materiality recent filing
Q3 net sales fell 8% to $882M, but organic sales grew 2% to $862M.
Central Garden & Pet to acquire 80% of TRIXIE for up to €400M
Upfront cash consideration of ~€340M plus earn-out up to €60M based on 2026 performance.
Central Garden & Pet Q2 FY2026: record sales $906M, EPS $1.28, pet distribution partnership
Net sales $906M (+8.6% YoY); GAAP diluted EPS $1.28 vs $0.98; adjusted EBITDA $139M vs $123M.
Central Garden & Pet appoints new director, boosts buyback by $100M
Kay M. Schwichtenberg appointed to Board effective March 1, 2026; also joins Audit Committee.
Central Garden & Pet Q1 FY2026 revenue down 6%; GAAP EPS $0.11 vs $0.21
Net sales $617M vs $656M; GAAP diluted EPS $0.11; non-GAAP diluted EPS $0.21 flat YoY.
Central Garden & Pet FY2025 EPS $2.55; non-GAAP EPS $2.73; guides FY2026 $2.70+
Fiscal 2025 net sales $3.1B (-2% YoY); GAAP EPS $2.55 vs $1.62; non-GAAP EPS $2.73 vs $2.13.
Central Garden & Pet enters $600M credit facility, maturing 2030
New $600M senior secured asset-based revolving credit facility; accordion allows up to $1B.
Central Garden Q3 EPS $1.52, revenue $961M (-4%); reaffirms FY25 non-GAAP EPS ~$2.60
GAAP EPS $1.52 vs $1.19; non-GAAP EPS $1.56 vs $1.32; net income $95M, up 19%.
Central Garden & Pet raises fiscal 2025 non-GAAP EPS outlook to ~$2.60
FY2025 non-GAAP EPS now expected to be approximately $2.60, up from prior guidance.
Central Garden & Pet Q2 GAAP EPS $0.98 (up 5%), non-GAAP $1.04 (up 5%); reaffirms FY25 guidance
GAAP EPS $0.98 vs $0.93; non-GAAP EPS $1.04 vs $0.99; net income $64M (+3%).
Central Garden & Pet Q1 EPS $0.21 vs $0.01; net sales up 3% to $656M
Net sales $656M (+3% YoY); EPS $0.21 vs $0.01; net income $14M vs $0.4M.
Central Garden & Pet appoints Randal D. Lewis to board, boosts buyback by $100M
Appointed Randal D. Lewis, former Spectrum Brands EVP & COO, as director effective Dec 11, 2024.
Central Garden & Pet: FY 2024 GAAP EPS $1.62, non-GAAP $2.13; guides FY 2025 non-GAAP EPS at $2.20+
Fiscal 2024 net sales $3.2B (-3% YoY); GAAP EPS $1.62 (vs $1.88); non-GAAP EPS $2.13 (vs $2.07).
Central Garden & Pet appoints Niko Lahanas as CEO, Brad Smith as CFO
Niko Lahanas, former CFO, becomes CEO and joins Board effective Sept 29, 2024.
Central Garden & Pet Q3 net sales $996M (-3% YoY); GAAP EPS $1.19 vs $1.25
Non-GAAP EPS $1.32 vs $1.40 a year ago; Pet segment sales up 1%, Garden down 6%.
Central Garden & Pet Q2 2024 GAAP EPS $0.93 (up 29% YoY); revenue $900M (-1%); maintains FY guidance
GAAP EPS $0.93 vs $0.72 a year ago; Non-GAAP EPS $0.99.
Central Garden & Pet Q1 EPS $0.01 vs loss; maintains FY non-GAAP EPS guidance $2.50+
Net sales $635M (+1% YoY); GAAP EPS $0.01 vs -$0.16; adjusted EBITDA $37M vs $29M.
Central Garden & Pet FY2023 GAAP EPS $2.35, non-GAAP $2.59; guides FY2024 ≥$2.50
FY2023 net sales flat at $3.3B; GAAP EPS $2.35 vs $2.80 prior year; non-GAAP EPS $2.59.
CEO Tim Cofer departs; Beth Springer named interim CEO; reaffirms FY2023 guidance
Tim Cofer resigns as CEO effective Oct 6, 2023 to join Keurig Dr Pepper as COO, becoming CEO in Q2 2024.
Net sales $1,023M (+1%); gross margin expanded 80bps to 31.1% (GAAP), 160bps to 31.9% (Non-GAAP).
Central Garden & Pet Q2 EPS $0.90 vs $1.27; sales down 5% to $909M; FY23 EPS guidance $2.35+
Net sales $909M, down 5% YoY; GAAP EPS $0.90 vs $1.27; adjusted EBITDA $107M vs $131M.
Central Garden & Pet updates FY2023 EPS guidance to $2.35 or better; Q2 EPS ~$0.90
FY2023 EPS guidance reaffirmed at $2.35 or better; Q2 EPS expected ~$0.90.
Net sales $628M (-5% YoY); net loss $8M vs income $9M; loss per share $0.16 vs EPS $0.16.
Central Garden & Pet reports FY2022 EPS $2.80, guides FY2023 EPS $2.60-$2.80
FY2022 net sales $3.3B (+1% YoY); diluted EPS $2.80 (up from $2.75).
Central Garden & Pet Q3 sales down 2% to $1,015M; GAAP EPS $1.39 up $0.02
Net sales decreased 2% to $1,015M vs $1,037M prior year; organic sales down 5%.
Central Garden & Pet Q2 net sales up 2% to $954M, diluted EPS $1.27, reaffirms FY22 EPS $3.10+
Net sales $954M (+2% YoY); organic declined 3.5%. Gross margin 30.1% (+100 bps). Operating income $107M (+2%).
Central Garden & Pet Q1 net sales +12% to $661M; diluted EPS $0.16 vs $0.10 YoY
Q1 net sales $661M, +12% YoY; diluted GAAP EPS $0.16 (up from $0.10).
Central Garden & Pet reports record FY2021 revenue $3.3B, EPS $2.75; Q4 net loss $3M
Fiscal 2021 net sales $3.3B (+23% YoY); diluted EPS $2.75 vs $2.20 (25% increase).
Central Garden & Pet Q3 net sales +24% to $1,037M; raises FY21 EPS guidance to $2.45+
Q3 diluted EPS grew 8% to $1.37; GAAP net income $76M, up 11%.
the Board appointed Bradley G. Smith as the Company’s Chief Financial Officer and designated him an executive officer of the Company, effective September 29, 2024.
Mr. Lahanas will resign as the Company’s Chief Financial Officer effective September 28, 2024.
the Board appointed Nicholas Lahanas as the Company’s Chief Executive Officer and a member of the Board effective September 29, 2024.
Mr. Cofer resigned as the Company’s Chief Executive Officer effective October 6, 2023.
Effective as of the close of business on October 6, 2023, Mary Beth Springer, a member of the Company’s Board of Directors, will serve as the Company’s principal executive officer on an interim basis while the Company conducts a search for Mr. Cofer’s replacement as the Company’s Chief Executive Officer.
On September 18, 2023, Timothy P. Cofer, the Chief Executive Officer of Central Garden & Pet Company (the “Company”), announced his intention to resign as Chief Executive Officer, effective as of the close of business on October 6, 2023.
Mr. Yuhas’s resignation as General Counsel became effective on April 4, 2022 upon the appointment of the Company’s new general counsel.
Mr. Yuhas’s resignation as General Counsel will be effective on April 4, 2022 upon the appointment of the Company’s new general counsel.
On November 29, 2021, George A. Yuhas, General Counsel and Secretary of Central Garden & Pet Company (the “Company”) informed the Company of his intent to retire during 2022 once the Company appoints his successor.
On August 11, 2021, Central Garden & Pet Company (the “ Company ”) appointed Lisa Coleman to the Company’s Board of Directors effective September 26, 2021.
Max materiality 0.90 · Median 0.65 · Most common event earnings